Gregg L. Semenza, MD, Ph.D., Professor of Genetic Medicine

One of today’s preeminent researchers on the molecular mechanisms of oxygen regulation, Dr. Semenza has led the field in uncovering how cells adapt to changing oxygen levels. He is best known for his ground-breaking discovery of the HIF-1 (hypoxia-inducible factor 1) protein, which controls changes in gene expression in response to changes in oxygen availability. The discovery of HIF-1 has far-reaching implications for understanding and treating conditions, such as cancer and ischemic cardiovascular disease, in which hypoxia plays an important role in disease pathogenesis. 


https://www.hopkinsmedicine.org/profiles/details/gregg-semenza




Comments

Post a Comment

Popular posts from this blog

Defamation lawsuits against Leonid Schneider (author of the "For Better Science" blog)

Image
Leonid Schneider has lost at least two documented defamation lawsuits: one in 2016 at the Bavarian Regional Court in Würzburg related to the Walles trachea transplant case, and another in 2018 at the Kammergericht Berlin concerning his reporting on Paolo Macchiarini and Philipp Jungebluth. These cases have resulted in financial penalties and ongoing legal threats, including potential imprisonment. Other lawsuits or threats are mentioned, but specific outcomes are less clear from the available data.
Read more

Interview of Elisabeth Bik – Scientific Editorial Director at uBiome

Image
"uBiome is the leader in microbial genomics. We develop microbiome products for both consumers as well as for patients and clinicians.  We have developed two clinical products, SmartGut for gastrointestinal conditions, and SmartJane, which combines vaginal microbiome analysis with STI and HPV genotyping. These clinical products are clinician-prescribed and are reimbursable by most health insurance companies." Elisabeth Bik
Read more